https://www.selleckchem.com/pr....oducts/z-lehd-fmk-s7
ing and preventive measures to avoid negative sequelae in this vulnerable population.Premature ovarian failure (POF) is one of the common disorders found in women leading to 1% female infertility. Clinical features of POF are hypoestrogenism or estrogen deficiency, increased gonadotropin level, and, most importantly, amenorrhea. With the development of regenerative medicine, human mesenchymal stem cell (hMSC) therapy brings new prospects for POF. This study aimed to describe the types of MSCs currently available for POF therapy
Like
Comment
Share
